Clinical Trial Update: Removal of Doravirine by Hemodialysis in HIV-Infected Patients With End-stage Renal Disease (ESRD) [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluates how doravirine is removed by hemodialysis in HIV-infected patients with end-stage renal disease, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• HIV Infection

Drugs mentioned

• Doravirine (doravirine)

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: HIV-infected Participants With ESRD Undergoing Routine Hemodialysis | Phase 4 | Status: COMPLETED | Results posted: 2024-08-27